CCN4 and neoplasm: WISP-1 overexpression has been shown to enhance cell growth in ESCC cell lines and is closely correlated with tumor size, tumor type, lymph node metastasis and poor prognosis of ESCC [83], suggesting that WISP1 could be a clinical biomarker for a poor prognosis in ESCC.